Cargando…
Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline)
Virus-like nanoparticles (VLNPs) have been studied extensively as nanocarriers for targeted drug delivery to cancer cells. However, VLNPs have intrinsic drawbacks, in particular, potential antigenicity and immunogenicity, which hamper their clinical applications. Thus, they can be eliminated easily...
Autores principales: | Fam, See Yee, Chee, Chin Fei, Yong, Chean Yeah, Ho, Kok Lian, Mariatulqabtiah, Abdul Razak, Lau, Han Yih, Tan, Wen Siang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801929/ https://www.ncbi.nlm.nih.gov/pubmed/31623310 http://dx.doi.org/10.3390/ijms20194903 |
Ejemplares similares
-
Stealth Coating of Nanoparticles in Drug-Delivery Systems
por: Fam, See Yee, et al.
Publicado: (2020) -
Hepatitis B Virus-Like Particle: Targeted Delivery of Plasmid Expressing Short Hairpin RNA for Silencing the Bcl-2 Gene in Cervical Cancer Cells
por: Akwiditya, Made Angga, et al.
Publicado: (2021) -
An Influenza A Vaccine Based on the Extracellular Domain of Matrix 2 Protein Protects BALB/C Mice Against H1N1 and H3N2
por: Ong, Hui Kian, et al.
Publicado: (2019) -
Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response
por: Ninyio, Nathaniel Nyakaat, et al.
Publicado: (2021) -
Regulation of Proteolytic Activity to Improve the Recovery of Macrobrachium rosenbergii Nodavirus Capsid Protein
por: Selvaraj, Bethilda Anne, et al.
Publicado: (2021)